|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
01011 NT PHARMA
Nominal 
0.375 +0.105 (+38.889%) Non-current Assets
| 2024/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | 2020/12 RMB(K¥) | |
| Investment Properties | 0 | -- | 0 | 0 | 0 | 0 |
| Property, plant, equip. & others | 543 | -42.479% | 944 | 495,717 | 222,367 | 419,830 |
| Land & other Lease Assets | 0 | -- | 0 | 0 | 25,998 | 117,998 |
| Intangible Assets | 0 | -- | 195 | 158,985 | 160,835 | 162,846 |
| Interests in Asso. & JCEs | 0 | -- | 312,960 | 277,013 | 277,936 | 16,899 |
| Other Non-current Assets | 317,347 | 11456.701% | 2,746 | 569 | 521 | 537 |
| 317,890 | 0.330% | 316,845 | 932,284 | 687,657 | 718,110 | |
Current Assets
| 2024/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | 2020/12 RMB(K¥) | ||
| Inventories | 168 | -- | 0 | 10,318 | 32,005 | 27,287 | |
| Trade Receivables | 0 | -- | 10,052 | 33,666 | 12,452 | 25,964 | |
| Cash & Bank Balances | 9,623 | 533.092% | 1,520 | 5,931 | 9,443 | 7,694 | |
| Other Current Assets | 6,394 | 806.950% | 705 | 23,519 | 33,803 | 419,915 | |
| Assets Held for Sale | 0 | -- | 0 | 0 | 180,000 | 96,099 | |
| 16,185 | 31.832% | 12,277 | 73,434 | 267,703 | 576,959 | ||
Current Liabilities
| 2024/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | 2020/12 RMB(K¥) | |||
| Trade Payables | 498 | -48.871% | 974 | 8,477 | 44,630 | 46,697 | ||
| S-T Debt & Leases | 367,836 | 7.762% | 341,342 | 825,991 | 618,430 | 799,404 | ||
| Other Current Liabilities | 356,731 | 10.521% | 322,771 | 335,225 | 232,913 | 255,669 | ||
| Liab asso w/ Assets Held for Sale | 0 | -- | 0 | 0 | 0 | 54,666 | ||
| 725,065 | 9.018% | 665,087 | 1,169,693 | 895,973 | 1,156,436 | |||
| Net Current Assets | (708,880) | 8.589% | (652,810) | (1,096,259) | (628,270) | (579,477) | ||
| Total Assets Less Current Liabilities | (390,990) | 16.378% | (335,965) | (163,975) | 59,387 | 138,633 | ||
Non-current Liabilities
| 2024/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | 2020/12 RMB(K¥) | ||||
| L-T Debt & Leases | 8,118 | 125.500% | 3,600 | 463 | 213,680 | 52,051 | |||
| Other Non-current Liabilities | 0 | -- | 0 | 77,220 | 57,082 | 64,160 | |||
| 8,118 | 125.500% | 3,600 | 77,683 | 270,762 | 116,211 | ||||
Capital and Reserves
| 2024/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | 2020/12 RMB(K¥) | |||||
| Share Capital | 1 | 0.000% | 1 | 1 | 1 | 1 | ||||
| Reserves | (399,109) | 17.535% | (339,566) | (241,659) | (211,376) | 16,278 | ||||
| Others | 0 | -- | 0 | 0 | 0 | 0 | ||||
| Shareholders' Funds | (399,108) | 17.535% | (339,565) | (241,658) | (211,375) | 16,279 | ||||
| Non-controlling Interests | 0 | -- | 0 | 0 | 0 | 6,143 | ||||
| Others | 0 | -- | 0 | 0 | 0 | 0 | ||||
| (399,108) | 17.535% | (339,565) | (241,658) | (211,375) | 22,422 | |||||
Commitments and Contingent Liabilities
| 2024/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | 2020/12 RMB(K¥) | |
| Commitments | -- | -- | 1,440 | 20,000 | 20,000 | 380,510 |
| Contingent Liabilities | -- | -- | 0 | 0 | 0 | 0 |
| Remarks: | Real time quote last updated: 22/04/2025 17:59 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service | |
| Profit / (Loss) Attributable to Shareholders (¥) | RMB -53,357,000 |
| %Change | -62.841% |
| EPS / (LPS) | RMB -0.202 |
| NBV Per Share (¥) | RMB -1.511 |